Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Obsessive-Compulsive Disorder
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

Evaluate the therapeutic effect of a functional Magnetic Resonance Imaging (fMRI)-guided and robotized neuronavigated theta burst Transcranial Magnetic Stimulation (TMS) targeting right inferior frontal region in resistant obsessive compulsive disorder (OCD) in a double-blind, randomized, placebo-controlled, monocentric study.

Provided treatments

  • Device: Active Repetitive Transcranial Magnetic Stimulation
  • Device: Placebo Repetitive Transcranial Magnetic Stimulation
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02884674. The sponsor of the trial is University Hospital, Grenoble and it is looking for 56 volunteers for the current phase.
Official trial title:
Stimulation magnétique transcrânienne répétitive Dans le Traitement Des Troubles Obsessionnels Compulsifs